Ovarian Cancer Risk Doubled by Estrogen-Only HRTJune 12, 2024Gynecologic CancerPatient & Survivor CarePreventive CareBreast Cancer
Features of Merkel Cell in Hispanic Patients ExploredJune 12, 2024Nonmelanoma Skin CancerDiversity in Medicine
Chemo May Benefit Some Older Patients With Metastatic Pancreatic CancerJune 11, 2024Gastrointestinal CancerPatient & Survivor CareGastroenterology
HPV Vaccine Offers Cancer Protection Beyond Cervical CancerJune 11, 2024Gynecologic CancerGenitourinary CancerPreventive CarePatient & Survivor CareHead & Neck/Thyroid Cancers
The Appendix: Is It ’Useless,’ or a Safe House and Immune Training Ground?June 10, 2024Gastroenterology
Are Children Born Through ART at Higher Risk for Cancer?June 10, 2024Preventive CarePediatricsBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
About 20% of Breast Cancer Survivors Gain Excess WeightJune 10, 2024Breast CancerPatient & Survivor Care
T-DXd Moves Toward First Line for HER2-Low Metastatic BCJune 10, 2024Metastatic Breast CancerBreast CancerPatient & Survivor CareASCO Breast Cancer
FDA Approves First-in-Class Drug for Lower-Risk Myelodysplastic SyndromesJune 7, 2024Leukemia, Myelodysplasia, Transplantation
‘Practice Changing’ Results for Osimertinib in Unresectable Stage III EGFR+ NSCLCJune 6, 2024Lung Cancer
Anti-Müllerian Hormone Predicts Chemo Benefits in BCJune 6, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
